Boston University and Banner Health researchers say a blood test may eventually allow doctors to detect chronic traumatic encephalopathy (CTE) while a person is still alive. The study, published in The Journal of the American Medical Association, examined blood samples from 21 former football players who later donated their brains for research.
Study findings
Autopsies confirmed CTE in 18 of the participants—16 with high‑stage disease and two with low‑stage disease—while three showed no signs of CTE. The scientists measured levels of a blood protein called eMTBR‑tau and found it was significantly higher in those with high‑stage CTE compared with the low‑stage or CTE‑negative groups. A second protein, p‑tau217, was elevated only in participants who also had Alzheimer’s disease.
Lead co‑author Michael Alosco, co‑director of clinical research at the BU CTE Center, explained that the marker is linked to tau tangles, a hallmark of both CTE and Alzheimer’s. “These findings could eventually support clinical trials and research into treatments,” Alosco said.
Context and corroboration
The Boston team noted that another study appearing in the same JAMA issue reported similar elevations of eMTBR‑tau in a separate group of individuals with autopsy‑confirmed CTE, using a different laboratory method. This independent confirmation strengthens the case that eMTBR‑tau may serve as a reliable biomarker for the disease.
Limitations and next steps
Researchers cautioned that the results are preliminary. The sample size was small, included few low‑stage cases, and lacked age‑matched control participants. The blood test is not yet FDA‑approved and is not available to the public; it should not be used for diagnostic decisions at this time.
The study teams continue to enroll participants. Individuals interested in contributing can join the Concussion & CTE Foundation’s research registry, which aims to expand the data set and refine the test’s accuracy.
Implications for families and athletes
If validated in larger trials, a blood‑based screening tool could give families, coaches, and medical professionals earlier insight into the risk of CTE, allowing for more informed decisions about participation in contact sports and potential early‑intervention strategies.
For now, the research underscores the importance of continued investigation into brain health for athletes who experience repeated head impacts.
Original reporting: WMUR (Hearst) – local news — read the source article.